Health Robotics is one of the most successful companies in the world in its field. In the seven short years since it was founded in 2006, the company has managed to capture more than 80 percent of the total IV Robots market and 90 percent of the Oncology Robots global market.
The extension of the partnership between Health Robotics and Tosho Inc., one of the leading manufacturers of medication dispensing machineries in Japan, will provide both companies access to new technology because of the transfer of knowledge taking place between the two organizations.
The Health Robotics system is installed in over 300 top hospitals in five continents around the world. The system provides a fully-integrated robotics-based technology that gives hospitals a better safety environment for their patients, increase throughput and save a substantial amount of money in the application of this medical procedure.
Hospitals spend a lot of money on Outsourced and Pre-mix IV products for the different conditions they treat. Installing an automated robotic system gives them better control systems for the medications they apply to their patients, while reducing the labor expenses associated with making the IVs.
This system produces ready-to-administer IVs that are sterile, accurate and tamper-evident to ensure the safety of the product.
The contract for the extension was signed in November and December of 2012 for the exclusive partnership with Tosho, Inc. The new contract gives Tosho more control over the robotic software and hardware components of Health Robotics’ medical devices, plus other technology transfer manufacturing to Japan.
"Now that we have gathered sufficient technical and market expertise with Health Robotics' developed products, the time has come to give Japanese customers what they have been requesting for so long: a local IV Robot manufacturer that can continue our proud Robotics traditions, and especially the cultural affinity of the Japanese market for the use of Robotics. This represents a tremendous competitive advantage for Tosho and Health Robotics in Japan over the alternative of importing foreign-manufactured IV robots," said Yoshihito Omura, CEO at Tosho, Inc.
Health Robotic has been searching for a reliable manufacturing in the past. These endeavors, however, did not pan out until the collaboration with Tosho.
Gaspar DeViedma, Health Robotics' executive vice president and Board Member, said, “Ceding control to Tosho over Japanese' made IV consumables already supported by our Robots (such as Terumo, Hikari, and Otsuka needles, IV Bags, syringes, and IV Bottles) will result in a competitive advantage for both Health Robotics and Tosho.”
Edited by
Braden Becker
